Bengaluru, India

Mathiyazhagan Rengasamy

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mathiyazhagan Rengasamy: Innovator in Ischemia Management

Introduction

Mathiyazhagan Rengasamy is an esteemed inventor based in Bengaluru, India, known for his contributions to the field of medical science, particularly in the management of ischemic conditions. With a focus on innovative therapeutic solutions, he has developed significant advancements that hold promise for improving patient outcomes.

Latest Patents

Rengasamy holds a patent titled "Management of ischemia using pooled mesenchymal stromal cell composition." This patent describes a composition that comprises pooled and expanded allogeneic mesenchymal stromal cells (MSCs) and a method for managing ischemia using this composition. The invention emphasizes bone marrow-derived pooled and expanded allogeneic MSC compositions, outlining effective dosage ranges and modes of administration. Additionally, the patent highlights the use of conditioned medium rich in bioactive factors in conjunction with the cell composition for the management of ischemic conditions.

Career Highlights

Currently, Mathiyazhagan Rengasamy is associated with Stempeutics Research Pvt. Ltd., where he leverages his expertise to push the boundaries of cellular therapy. His innovative approach and dedication have made him a vital contributor to the company's mission of advancing regenerative medicine.

Collaborations

Rengasamy collaborates with notable colleagues such as Anish Sen Majumdar and Pawan Kumar Gupta. Together, they form a dynamic team, sharing insights and expertise to further their research and development efforts in the field of cell-based therapies.

Conclusion

Mathiyazhagan Rengasamy’s work in the realm of ischemia management through innovative use of mesenchymal stromal cells represents a significant leap in medical science. With his strong foundation in research and collaboration, he continues to pave the way for breakthroughs that may one day transform treatment protocols for ischemic conditions. His commitment to innovation exemplifies the spirit of advancement in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…